Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies

Hepatology

Volumn 32, Issue 5, 2000, Pages 942-946

  Maggioni, Marco ^a   Coggi, Guido ^a   Cassani, Barbara ^a   Bianchi, Paolo ^b   Romagnoli, Solange ^a   Mandelli, Alessandra ^a   Borzio, Mauro ^c   Colombo, Piergiuseppe ^b   Roncalli, Massimo ^b  

^a SAN PAOLO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; DYSPLASIA; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HYPERPLASIA; MICROSATELLITE INSTABILITY; NEEDLE BIOPSY; PRIORITY JOURNAL;

EID: 0033754784     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.18425     Document Type: Article

References (31)

1. Terminology of nodular hepatocellular lesions
2. Atypical adenomatous hyperplasia in liver cirrhosis: Low-grade hepatocellular carcinoma or borderline lesion?
3. Adenomatous hyperplasia of the liver as a precancerous lesion
4. Ultrasonography detected macroregenerative nodules in cirrhosis: A prospective study
5. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen
6. Adenomatous hyperplasia in cirrhotic livers: Histological evaluation, cellular density, and proliferative activity of 35 macronodular lesions in the cirrhotic explants of 10 adult French patients
7. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: Implications for diagnosis and classification
8. DNA cytometric analysis of macroregenerative nodules (adenomatous hyperplasia) of the liver: Evidence in support of their preneoplastic nature
9. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma
10. Clonal analysis of precancerous lesion of hepatocellular carcinoma
11. Clonal analysis of macronodules in cirrhosis
12. Selected G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
13. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
14. p53 mutation and overexpression in hepatocellular carcinoma and dysplastic nodules in the liver
15. Loss of heterozygosity in liver tumors
16. Comprehensive allelotyping of human hepatocellular carcinoma
17. Allelotype analysis of hepatocellular carcinoma
18. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by high-resolution allelotype
19. Frequent microsatellite instability in post hepatitis B viral cirrhosis
20. Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma
21. Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis
22. Loss of heterozygosity and microsatellite instability in human non-neoplastic hepatic lesions
23. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
24. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver
25. Semiautomated assessment of loss of heterozygosity and replication error in tumors
26. Cell-cycle related gene abnormalities and product expression in esophageal carcinoma
27. Allelotype of colorectal carcinomas
28. Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesion arising in chronic advanced liver disease
29. Fractional allelic loss in non end-stage cirrhosis: Correlations with hepatocellular carcinoma development during follow up
30. Low proliferative activity in macroregenerative nodules: Evidence for an alternate hypothesis concerning human hepatocarcinogenesis
31. Replication error frequencies in primary hepatocellular carcinoma: A comparison of solitary versus multiple primary cancers